Sarkana Pharma
Wilmington, US · Founded 2020 · Delaware corporation · 1 known investors
Find your way into Sarkana Pharma
Sign up to find every way you can get introduced to Sarkana Pharma
- Your email: who you already know at Sarkana Pharma, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Sarkana Pharma team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
CF
Caroline FortierNamed on SEC filing
LM
Luc MarengereNamed on SEC filing
MC
Mark CiprianoNamed on SEC filing
Investors · 1
TVM Life Science Innovation SCSpreportedSenningerberg
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 1 round · 2020
▶$1.6MraisedFeb 2021 · 1 investors · PharmaceuticalsRule 506(b)
▶$1.6MraisedFeb 2021 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Caroline FortierExecutive Officer
- Luc MarengereDirector
- Mark CiprianoExecutive Officer
- Amount sold
- $1.6M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Sarkana Pharma's investors?
- Sarkana Pharma's investors include TVM Life Science Innovation SCSp.
- How much funding has Sarkana Pharma raised?
- Sarkana Pharma has disclosed $1.6M raised across 1 round.
- Where is Sarkana Pharma headquartered?
- Sarkana Pharma is headquartered in Wilmington, US.